Kazia Therapeutics Limited American Depositary Shares
N/A
USD
N/A
N/A
...
Chart
Financials
Description
KZIA Company Description
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors.
KZIA Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view KZIA Smart Score
Score Breakdown
KZIA Company Description
Show More
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of KZIA by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by KZIA's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on KZIA's company Twitter account
WallStreetBets
Number of mentions of KZIA in WallStreetBets Daily Discussion
KZIA News
Recent insights relating to KZIA
CNBC Recommendations
Recent picks made for KZIA stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in KZIA
Corporate Flights
Flights by private jets registered to KZIA
Our Analysis